arrow
K

Kylie L. Gorringe

Peter MacCallum Cancer Centre
H指数:40
被引数:6,458

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gene Expression Biomarkers for Breast Ductal Carcinoma in Situ Recurrence Prediction

乳腺导管原位癌复发预测的基因表达生物标志物

2026-09-250
OAAI
The Drp1 inhibitor DRP1i2 confers cardioprotection against doxorubicin-induced cardiotoxicity

Drp1i2抑制剂可对抗多柔比星诱导的心脏毒性,从而发挥心脏保护作用

2026-08-210
OA
Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression

配对乳腺癌的谱系分析识别与克隆性复发和侵袭性进展相关的遗传事件

2025-10-300
OAAI
Stromal lymphocytes are associated with upgrade of B3 breast lesions
2024-07-080
OAAI
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2022-10-0711
OAAI
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
2022-06-2914
OAAI
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas

经过验证的生物标志物检测证实,ARID1A丢失与MMR缺乏,CD8 TIL浸润混淆,并且在子宫内膜异位症相关的卵巢癌中没有独立的预后价值。

2022-02-0721
OA